Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort studyNicole M. Kuderer, Kerry L. Reynolds, Toni K. Choueiri et al.|The Lancet|2020Cited by 1.8k
Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung CancerAlexander Drilon, Vivek Subbiah, Takashi Seto et al.|New England Journal of Medicine|2020Cited by 835
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020John A. Thompson, Anita M. Engh, Bryan J. Schneider et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 484
A Phase II Study of Gefitinib in Patients with Advanced Thyroid CancerNathan A. Pennell, Thomas J. Lynch, Lori J. Wirth et al.|Thyroid|2007Cited by 198
Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancerArvind Ravi, Justin F. Gainor, Matthew D. Hellmann et al.|Nature Genetics|2023Cited by 185